DELFI Diagnostics

Developing blood-based tests for early cancer detection.

BiotechnologyDiagnostics delfidiagnostics.com ↗

Company facts

Founded
2019
Employees
175
Headquarters
United States
Type
Private
Funding
Series B · $225M · 2022